争议事件
以下收录公开来源中与该品牌相关的争议事件。列出一条并不表示过错已经证实。
返回词条共 1 条
2017
默克与百时美施贵宝及小野制药就PD-1专利诉讼达成和解
和解
默克同意向百时美施贵宝和小野制药支付6.25亿美元及Keytruda销售提成，以解决涉及PD-1抑制剂的专利侵权诉讼。协议规定撤销针对默克提起的专利诉讼。
来源摘录
The US drugmaker has agreed to pay Bristol-Myers Squibb and Ono Pharmaceutical $625m to settle the patent infringement litigation – focusing on intellectual property in the area of PD-1 inhibitors – and will also pay a 6.5% royalty on sales of Keytruda (pembrolizumab) through to December 2023.
Phil Taylor 23rd January 2017